Alexandr Mandzhulo, Iryna Vashchenko, Oleg Lukin, Svetlana Shishkina, Grygoriy Dolgonos, Andrii Gerasov, Vitaliy Yepishev, Dariia Samofalova, Volodymyr Fetyukhin, Alexander Shivanyuk
{"title":"正托烷和 1,3-恶嗪酮-2-酮片段的螺环杂化物","authors":"Alexandr Mandzhulo, Iryna Vashchenko, Oleg Lukin, Svetlana Shishkina, Grygoriy Dolgonos, Andrii Gerasov, Vitaliy Yepishev, Dariia Samofalova, Volodymyr Fetyukhin, Alexander Shivanyuk","doi":"10.1055/a-2335-4444","DOIUrl":null,"url":null,"abstract":"<p>We report facile and versatile procedures for the synthesis of <i>exo</i>- and <i>endo</i>-isomeric spirocyclic hybrids of pharmacophoric (1<i>R</i>,5<i>S</i>)-8-azabicyclo[3.2.1]octane (nortropane) and 1,3-oxazinan-2-one fragments. Our approach consists of the hydrocyanation of <i>endo</i>- and <i>exo</i>-isomeric <i>N</i>-Cbz-protected nortropane-3-spiroepoxides, the reduction of hydroxy nitriles into amino alcohols, the synthesis of <i>N</i>-alkylated amino alcohols <i>via</i> reductive amination, the spirocyclization of the amino alcohols, <i>N</i>-alkylation of the unsubstituted 1,3-oxazinan-2-one fragment in the spiro compounds, and removal of the Cbz protecting groups.</p> ","PeriodicalId":501298,"journal":{"name":"Synthesis","volume":"17 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Spirocyclic Hybrids of Nortropane and 1,3-Oxazinan-2-one Fragments\",\"authors\":\"Alexandr Mandzhulo, Iryna Vashchenko, Oleg Lukin, Svetlana Shishkina, Grygoriy Dolgonos, Andrii Gerasov, Vitaliy Yepishev, Dariia Samofalova, Volodymyr Fetyukhin, Alexander Shivanyuk\",\"doi\":\"10.1055/a-2335-4444\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We report facile and versatile procedures for the synthesis of <i>exo</i>- and <i>endo</i>-isomeric spirocyclic hybrids of pharmacophoric (1<i>R</i>,5<i>S</i>)-8-azabicyclo[3.2.1]octane (nortropane) and 1,3-oxazinan-2-one fragments. Our approach consists of the hydrocyanation of <i>endo</i>- and <i>exo</i>-isomeric <i>N</i>-Cbz-protected nortropane-3-spiroepoxides, the reduction of hydroxy nitriles into amino alcohols, the synthesis of <i>N</i>-alkylated amino alcohols <i>via</i> reductive amination, the spirocyclization of the amino alcohols, <i>N</i>-alkylation of the unsubstituted 1,3-oxazinan-2-one fragment in the spiro compounds, and removal of the Cbz protecting groups.</p> \",\"PeriodicalId\":501298,\"journal\":{\"name\":\"Synthesis\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Synthesis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2335-4444\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Synthesis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2335-4444","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Spirocyclic Hybrids of Nortropane and 1,3-Oxazinan-2-one Fragments
We report facile and versatile procedures for the synthesis of exo- and endo-isomeric spirocyclic hybrids of pharmacophoric (1R,5S)-8-azabicyclo[3.2.1]octane (nortropane) and 1,3-oxazinan-2-one fragments. Our approach consists of the hydrocyanation of endo- and exo-isomeric N-Cbz-protected nortropane-3-spiroepoxides, the reduction of hydroxy nitriles into amino alcohols, the synthesis of N-alkylated amino alcohols via reductive amination, the spirocyclization of the amino alcohols, N-alkylation of the unsubstituted 1,3-oxazinan-2-one fragment in the spiro compounds, and removal of the Cbz protecting groups.